< back to News

IMPACT-AML will be represented at the ERN-EuroBloodNet Board of Network Meeting, taking place during the European Hematology Association (EHA) Annual Congress 2026 in Stockholm.

Prof. Giovanni Martinelli, Scientific Coordinator of IMPACT-AML, has been invited as a speaker for this important meeting, scheduled on Friday, 12 June 2026, from 9:00 to 12:45 (CEST) at the Stockholmsmässan (Room K21, Auditorium).

During Session 1, dedicated to the EU Action Plan for Rare Diseases, Prof. Martinelli will present the vision and ongoing progress of the IMPACT-AML project, highlighting its contribution to innovation and collaboration within the European reference community for rare hematological disorders.

IMPACT-AML builds a pioneering research framework for Relapsed or Refractory Acute Myeloid Leukemia, bringing together patients, clinicians, and researchers across Europe and beyond. At its core, the STREAM platform enables the integration of real-world evidence and supports pragmatic clinical trials, laying the foundation for more patient-centric treatments and driving collaborative innovation in AML care. This participation underscores IMPACT-AML’s commitment to strengthening partnerships, advancing research, and improving care pathways for patients with rare blood diseases across Europe.

Find out more in the AGENDA.